Related references
Note: Only part of the references are listed.Ligustilide promotes apoptosis of cancer-associated fibroblasts via the TLR4 pathways
Jing Ma et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases-Current State of the Art
Karina Smorodinsky-Atias et al.
CELLS (2020)
Ligustilide modulates oxidative stress, apoptosis, and immunity to avoid pathological damages in bleomycin induced pulmonary fibrosis rats via inactivating TLR4/MyD88/NF-KB P65
Shu Luo et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Ligustilide inhibits the activation of cancer-associated fibroblasts
Jing Ma et al.
LIFE SCIENCES (2019)
Apoptotic cell death induced by Z-Ligustilidein human ovarian cancer cells and role of NRF2
Fangfang Lang et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy
D. Matthew Gianferante et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Z-ligustilide restores tamoxifen sensitivity of ERα negative breast cancer cells by reversing MTA1/IFI16/HDACs complex mediated epigenetic repression of ERα
Hui Ma et al.
ONCOTARGET (2017)
Sensitization of tamoxifen-resistant breast cancer cells by Z-ligustilide through inhibiting autophagy and accumulating DNA damages
Hongyi Qi et al.
ONCOTARGET (2017)
Molecular genetics of osteosarcoma
Kirby Rickel et al.
BONE (2017)
Programmed cell death and the immune system
Shigekazu Nagata et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database
Kyle R. Duchman et al.
CANCER EPIDEMIOLOGY (2015)
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
Michael S. Isakoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
Lisa Mirabello et al.
CANCER DISCOVERY (2015)
Targeting RAS-ERK signalling in cancer: promises and challenges
Ahmed A. Samatar et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Epigenetic Reactivation of Nrf2 in Murine Prostate Cancer TRAMP Cl Cells by Natural Phytochemicals Z-Ligustilide and Radix Angelica Sinensis via Promoter CpG Demethylation
Zheng-Yuan Su et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2013)
The Effect of Z-Ligustilide on the Mobility of Human Glioblastoma T98G Cells
Jun Yin et al.
PLOS ONE (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
Study of the anti-proliferative effects and synergy of phthalides from Angelica sinensis on colon cancer cells
Winnie Lai Ting Kan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2008)
Osteosarcoma, chondrosarcoma, and Ewing's sarcoma
Timothy A. Damron et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2007)
Cytotoxic constituents from Angelicae Sinensis Radix
Quan Cheng Chen et al.
ARCHIVES OF PHARMACAL RESEARCH (2007)
Live or let die: The cell's response to p53
KH Vousden et al.
NATURE REVIEWS CANCER (2002)
Share Paper
